Harvard Center for neurodegeneration & repair to collaborate with GE Healthcare centered on Cellular Analysis
The IN Cell systems will primarily be used for HCNR members investigating neurodegenerative diseases and the central nervous system. GE Healthcare has provided HCNR with a sophisticated software package to accompany the instrument, which includes prepackaged, fully validated analysis routines for rapid analysis of a range of biological processes. The IN Cell Developer Toolbox has also been provided to HCNR members to accommodate applications where the pre-developed analysis routines are not suitable. Developer Toolbox gives users the flexibility to develop new cellular assay routines from a menu of pre-programmed sub routines. Simultaneously, HCNR and GE Healthcare are working together to develop the image analysis software.
"Despite the fact that assay development and associated instrumentation have matured to the stage that high throughput, image-based screening is feasible, there is a bottleneck around image analysis," said Stephen Wong, PhD, P.E., Director of the HCNR Center for Bioinformatics, and an associate professor of radiology at Harvard Medical School. "Most scientists still rely upon slow, manual analysis to extract information. This new imaging toolkit has the potential to relieve this bottleneck. We look forward to investigating new applications and tools to improve our ability to perform high content analyses."
Most read news
Topics
Organizations
Other news from the department science
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
LAUDA.LIVE by LAUDA
LAUDA.LIVE - The digital platform for your device management
Comprehensive fleet management options for every LAUDA device - with and without IoT connectivity
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.